By Abigail Townsend
Date: Wednesday 06 May 2026
(Sharecast News) - Shares in Denmark's Novo Nordisk sparked on Wednesday after sales of its new fat-busting pill smashed forecasts.
Updating on first-quarter trading, the drugs giant said total weekly prescriptions of the Wegovy pill - which launched in the US on 5 January - exceeded 200,000, with sales in the...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news